Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson's Disease.

Similar trends were found in relation with inducible nitric oxide synthase (iNOS; F(3,49) = 0.839, ns) and cyclooxygenase-2 (COX-2; F(3,51) = 1.031, ns) ( Figure 7 ), although the differences did not reach statistical significance in most cases, partly due to the high variability in the lesioned groups, in particular in vehicle-treated LPS-lesioned mice. 3.

also in 111,027 other papers